Adam Snook, PhD

Adam Snook, PhD

Contact Dr. Snook

1020 Locust Street
JAH 368E
Philadelphia, PA 19107

(215) 503-7445
(215) 955-7006 fax

Most Recent Peer-reviewed Publications

  1. Human GUCY2C-targeted chimeric antigen receptor (CAR)-expressing T cells eliminate colorectal cancer metastases
  2. Immunotherapy regimens for metastatic colorectal carcinomas
  3. CD4+T cells: The nexus of tolerance, autoimmunity and tumor immunity
  4. Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors
  5. Immunotherapy in Colorectal Cancer: Where Are We Now?
  6. The heat-stable enterotoxin receptor, guanylyl cyclase C, as a pharmacological target in colorectal cancer immunotherapy: A bench-to-bedside current report
  7. GUCY2C signaling opposes the acute radiation-induced GI syndrome
  8. ST-producing E. Coli oppose carcinogen-induced colorectal tumorigenesis in mice
  9. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  10. The swinging pendulum of cancer immunotherapy personalization
  11. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+T cells
  12. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  13. RB loss promotes prostate cancer metastasis
  14. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  15. GUCY2C maintains intestinal LGR5+stem cells by opposing ER stress
  16. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  17. GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
  18. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  19. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  20. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis